Intensive Transition Support for Medically Complex Youth
(PITCare Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on providing support during the transition to adult care, so it's best to ask the trial coordinators for more details.
What data supports the effectiveness of the treatment Intensive Transition Support for Medically Complex Youth?
Research shows that coordinated care models can improve health outcomes for children with medical complexity during transitions. Additionally, interventions focusing on hospital-to-home transitions have been linked to better life impact and resource use outcomes, suggesting that structured support can be beneficial.12345
Is Intensive Transition Support for Medically Complex Youth safe for humans?
The available research highlights the importance of coordinated care and communication for children with medical complexity, but it does not provide specific safety data for Intensive Transition Support. Families of these children often identify safety and quality gaps in hospital care, suggesting that while the approach aims to improve transitions, safety concerns may still exist.14678
How is the Intensive Transition Support treatment different from other treatments for medically complex youth?
The Intensive Transition Support treatment is unique because it focuses on providing coordinated care and support during the transition from pediatric to adult care for medically complex youth, addressing both physical and mental challenges. This approach aims to improve health outcomes by easing the transition process, which is often complex due to differences in pediatric and adult healthcare systems.19101112
What is the purpose of this trial?
Medical advances have allowed many more children and youth with medical complexity (CMC) to survive well into adulthood. However, this has not been matched with increases in knowledge of complex conditions or the availability of supports as they transition into the adult care system. The goal of this randomized control trial is to compare intensive transition support from a transition team, led by an advance practice nurse, during transition to adult care for 2 years, with usual care in CMC. Participants assigned to the intervention group will be offered support in care planning, receiving funding, and connecting with a primary care provider and adult subspecialists.The main questions it aims to answer are:1. Does intensive transition support improve the patient's continuity of care over 2 years compared with usual care?2. Will there be differences between intervention and control groups with respect to other outcomes related to the youth/family's satisfaction with care, care coordination, self-care, health service utilization, cost-effectiveness, and quality of life?3. What are the experiences of youth, parents, the transition team, and other clinicians involved in the intensive transition support process?
Eligibility Criteria
This trial is for children and youth with complex medical needs who rely on technology, face severe or life-threatening conditions, expect their condition to last at least 6 months, and are involved with multiple healthcare teams in various locations. It's not specified who can't join.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intensive Transition Support
Participants receive intensive transition support from a transition team, led by an advance practice nurse, during transition to adult care
Follow-up
Participants are monitored for continuity of care, satisfaction, and other outcomes after transition support
Treatment Details
Interventions
- Intensive Transition Support
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Hospital for Sick Children
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator